Name | Market | Market CAP | Share price | Daily share movement |
---|---|---|---|---|
ABx Group Ltd | ASX | $13.75 m | 0.06 AUD | 1.85% |
Acacia Research | NASDAQ | $541.43 m | 5.42 USD | 2.65% |
Acceler8 Ventures PLC | LSE | £1.43 m | 190.00 GBX | 0.00% |
Accelerate Resources Ltd | ASX | $24.4 m | 0.04 AUD | 0.00% |
Acceleware Ltd | TSX-V | $13.61 m | 0.12 CAD | 15.00% |
Accenture PLC | NYSE | $215.21 b | 342.75 USD | 0.53% |
Access Intelligence Group | AIM | £70.23 m | 55.00 GBX | 0.92% |
Accesso Technology Group PLC | AIM | £222.91 m | 535.00 GBX | 0.75% |
Acciona S.A. | OTC | $6.4 b | 117.88 USD | -1.23% |
Accrol Group Holdings PLC | AIM | £123.12 m | 38.61 GBX | 0.03% |
Accsys Technologies | AIM | £148.37 m | 62.00 GBX | 5.08% |
AccuStem | OTCQB | $4.17 m | 0.37 USD | -0.77% |
ACDC Metals Ltd | ASX | $4.12 m | 0.06 AUD | 14.00% |
ACG Acquisition Company Ltd | LSE | $69.17 m | 15.50 USD | 0.00% |
Achiko AG | OTCQB | $377.4 k | 0.00 USD | -50.00% |
Aclara Resources Inc | TSX | $81.66 m | 0.50 CAD | 16.28% |
Aclarion | NASDAQ | $2.37 m | 0.33 USD | 2.00% |
ACME Lithium Inc | CSE | $3.96 m | 0.07 CAD | 0.00% |
Acorda Therapeutics Inc | NASDAQ | $14.68 m | 11.82 USD | -2.31% |
ACP Energy PLC | LSE | £3.03 m | 6.50 GBX | 0.00% |